Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neuroblastoma 3 Ganglioneuroblastoma 2 Wilms Tumor 1 Neoplasms 1 Kidney Neoplasms 1

Interventions

X-Rays 9 Specimen Handling 8 Phantoms, Imaging 8 Magnetic Resonance Spectroscopy 8 Vincristine 5 Nuclear Medicine Department, Hospital 5 Biopsy 5 Doxorubicin 4 Etoposide 3 Dactinomycin 3 Cyclophosphamide 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 ensartinib 2 Temozolomide 2 Radiotherapy, Conformal 2 Radiotherapy 2 Radiation 2 LY3023414 2 Irinotecan 2 talazoparib 1 selinexor 1 pembrolizumab 1 olaparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Wilms Tumor × Isotretinoin × 90 days × Clear all

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡